栄研化学JP:4549バランスシート

時価総額
¥949.3億
PER
21.5倍
検査薬の製造販売を主な事業とし、中国では栄研生物科技が受託生産と仕入製造販売を手がける企業。
2014/032015/032016/032017/032018/032019/032020/032021/032022/032023/032024/032025/03
現金同等物-9,5908,24510,0399,7347,55410,0989,15016,12118,31716,3089,873
有価証券-------80----
売掛金-9,75610,23310,35611,71811,95911,01712,29811,95611,12212,48210,928
商品及び製品-3,2553,0863,2663,2633,5514,3424,4924,6734,7394,1704,576
流動資産合計-25,28524,62726,98327,19725,85228,90329,98337,03939,21737,85131,532
有形固定資産-7,1189,06711,68911,39111,09512,04112,76815,27517,20217,00522,121
投資有価証券-4433913894235553,4873,4103,614586597408
固定資産合計-12,61014,63917,26917,96821,42721,41825,70125,47327,05823,79930,840
総資産-37,89539,26644,25245,16547,27950,32255,68562,51266,27561,65162,372
買掛金-3,9644,1364,3464,4344,1484,5864,0444,4954,6854,6485,251
流動負債合計-9,99510,10912,67211,55010,98111,74012,77212,53312,44311,35114,376
固定負債合計-1,2609569701,1361,2841,2781,2394,1754,2964,3294,397
総負債-11,25511,06513,64212,68712,26513,01814,01216,70816,74015,68018,773
資本金及び資本剰余金-14,78914,78914,79114,79514,83214,83214,87014,89714,97314,78914,789
利益剰余金-14,83816,57118,75820,35922,86925,30229,16633,16236,86535,80134,700
株主資本24,27826,63928,20130,60932,47835,01437,30341,67245,80349,53545,97143,598